Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.00%
#4 aPriori aPriori +152.64%
#5 Bedrock Bedrock +71.59%
#6 Cysic Cysic +51.82%
#7 Prom Prom +46.77%
#8 Playnance Playnance +34.96%
#9 Bitway Bitway +28.81%
#10 COTI COTI +27.28%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Hydrogen Hybrid Technologies, Inc. Hydrogen Hybrid Technologies, Inc.

Hydrogen Hybrid Technologies, Inc.

HYHY
Rank in Stocks #42261
Hydrogen Hybrid Technologies, Inc. manufactures, sales and distributes on-board... Hydrogen Hybrid Technologies, Inc. manufactures, sales and distributes on-board hydrogen generating and injections systems for the original equipment manufacturers in car and light truck markets. Its on-board hydrogen generating system improves fuel consumption and reduces pollution through the enhancement of the internal combustion process. This technology consists of an on-board system, which generates hydrogen and oxygen by splitting distilled water. In addition, the company holds rights to distribute the product to other markets, including the heavy goods vehicle market. Hydrogen Hybrid Technologies, Inc. is based in Pickering, Canada.
Share Price
$0.00003
Last synced: 2026-08-11
Market Cap
$2.81K
Change (1 day)
0.00%
Change (1 year)
-85.00%
Country
CA
Trade Hydrogen Hybrid Technologies, Inc. (HYHY)

Category

Healthcare
Revenue for Hydrogen Hybrid Technologies, Inc. (HYHY)
Revenue in Aug 2026 TTM: 0
According to Hydrogen Hybrid Technologies, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hydrogen Hybrid Technologies, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US